As of now, clinical trials specifically targeting LPL in cancer are limited. Most research is still in the preclinical stage, focusing on understanding the enzyme's role and developing effective inhibitors. However, as our knowledge of LPL's involvement in cancer deepens, it is likely that clinical trials will emerge to test new therapeutic strategies.
